Guus Scheefhals
Directeur Général chez Crossbeta Biosciences BV
Provenance du réseau au premier degré de Guus Scheefhals
Entité | Type d'entité | Industrie | |
---|---|---|---|
Crossbeta Biosciences BV
Crossbeta Biosciences BV BiotechnologyHealth Technology Crossbeta Biosciences BV develops drug discovery programs in the area of misfolded protein diseases. It specializes in alzheimer's disease drug development and drug discovery platform services. The company was founded by Martijn Gebbink and Barend Bouma in 2005 and is headquartered in Utrecht, the Netherlands.
2
| Holding Company | Biotechnology | 2 |
DegenRx BV
DegenRx BV BiotechnologyHealth Technology DegenRx BV is a Dutch biotech company that is focused on developing AAV-mediated gene therapy for the treatment of CNS diseases such as Alzheimer's and Parkinson's disease. The company is based in Tilburg, Netherlands. The company aims to address the lack of drugs available to stop or slow down the progression of Alzheimer's disease, which affects about two-thirds of the 50 million people reported to suffer from dementia worldwide. One of the approaches most advanced in clinical studies is immunotherapy against amyloid beta, which DegenRx is working on. Inez de Greef-van der Sand has been the CEO of the company since 2020.
1
| Holding Company | Biotechnology | 1 |
DSM Biologics Holding, Inc.
DSM Biologics Holding, Inc. BiotechnologyHealth Technology Part of DSM-Firmenich AG, DSM Biologics Holding, Inc. is a Canadian company that manufactures biological and pharmaceutical products. The private company is based in Montréal, Canada. The company was founded by Jos van Weperen. DSM Biologics Holding was acquired by DSM Pharmaceuticals, Inc., a subsidiary of DSM-Firmenich AG from Province of Québec on July 13, 2005.
1
| Subsidiary | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Guus Scheefhals via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Founder | |
Abbott Healthcare Products BV
Abbott Healthcare Products BV Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, Abbott Healthcare Products BV is a Dutch company that manufactures and distributes pharmaceuticals. The company is based in Weesp, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Amsterdam | College/University | Doctorate Degree | |
University of Leiden | College/University | Undergraduate Degree | |
University of Utrecht | College/University | Doctorate Degree Corporate Officer/Principal | |
University of Groningen | College/University | Doctorate Degree | |
Polpharma Biologics Utrecht BV
Polpharma Biologics Utrecht BV Miscellaneous Commercial ServicesCommercial Services Polpharma Biologics Utrecht BV operates as a biopharmaceutical research and development company. It specializes in the development of monoclonal antibodies generation, cell line, upstream process, downstream process, analytical, and bioassay development services. The company is headquartered in Utrecht, the Netherlands. | Miscellaneous Commercial Services | Chairman | |
PharmaCell BV
PharmaCell BV BiotechnologyHealth Technology PharmaCell BV manufactures cell therapy and regenerative medicine. The firm engages in human cell line development and manufacturing of bio pharmaceuticals. Its services include process research and development, project management, incoming logistics, incoming goods, manufacturing auto logous and allogeneic products, quality control, final formulation, release and outgoing logistics. The company was founded by René Lardenoije and Jan Thio in 2005 and is headquartered in Maastricht, the Netherlands. | Biotechnology | Director/Board Member | |
Biogeneration Management BV
Biogeneration Management BV Investment ManagersFinance Biogeneration Management is a venture capital firm, a subsidiary of BioGeneration Holding BV and was founded in 2006. Biogeneration management is headquartered in Naarden. | Investment Managers | Private Equity Investor | |
Tanox Pharma BV | Chief Executive Officer | ||
MOLECULAR PARTNERS AG | Biotechnology | Corporate Officer/Principal | |
Oxyrane UK Ltd.
Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
ProFibrix BV
ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Chairman | |
Infection Control BV
Infection Control BV Medical SpecialtiesHealth Technology Infection Control BV designs, manufactures, markets and sells disinfection systems. It offers products to the clinics and hospitals. The company is headquartered in Eemnes, the Netherlands. | Medical Specialties | Corporate Officer/Principal | |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology DCPrime BV engages in the provision of therapeutic vaccines for the treatment of cancer. It develops whole-cell-based vaccine addressing blood cancers with a high risk of relapse. The company was founded by Ada M. Kruisbeek and Rik J. Scheper in March 2005 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
MENDUS AB | Biotechnology | Director/Board Member | |
UNIQURE N.V. | Biotechnology | Chief Operating Officer | |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
Fast Forward Pharmaceuticals BV
Fast Forward Pharmaceuticals BV Medical SpecialtiesHealth Technology Fast Forward Pharmaceuticals BV develops novel disease-modifying therapeutics for the treatment of inflammatory and autoimmune diseases. It is developing an anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The company was founded by Louis Boon in October 2010 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Chief Executive Officer | |
Rotterdam School of Management | College/University | Doctorate Degree | |
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member | |
Aristi Biotech BV
Aristi Biotech BV BiotechnologyHealth Technology Aristi Biotech BV is a service company dedicated to the preclinical development of monoclonal antibodies. It offers monoclonal antibody generation, cell line development and immunoassay development services. The company is headquartered in Utrecht, the Netherlands. | Biotechnology | Chief Executive Officer | |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Synerkine Pharma BV focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company was founded by Hans Preusting in 2018 and is headquartered in Utrecht, Netherlands. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistiques
Internationale
Pays-Bas | 27 |
Etats-Unis | 4 |
Belgique | 2 |
Suisse | 2 |
Royaume-Uni | 2 |
Sectorielle
Health Technology | 21 |
Commercial Services | 6 |
Consumer Services | 6 |
Finance | 2 |
Health Services | 2 |
Opérationnelle
Director/Board Member | 10 |
Chief Executive Officer | 9 |
Founder | 7 |
Corporate Officer/Principal | 7 |
Chairman | 5 |
Relations les plus connectées
- Bourse
- Insiders
- Guus Scheefhals
- Connexions Sociétés